Trading Sections

Dyne Therapeutics: Oppenheimer Raises Rating and Price Target - Experts See Doubling Potential!

Dyne Therapeutics (DYN) is a biotechnology company specialized in developing therapies for genetically...

UBS sees multiple positive factors for NRG Energy's rising stock prices – outside of the data center business. The upside potential is 27%.

The AI era will only progress if sufficient electricity is available. NRG Energy (NRG) is among the...

Mama’s Creations: From Penny Stock to Growth Star. Revenue Increase Accelerates to a Whopping 50% in Q3.

About ten years ago, the stock of Mama's Creations (MAMA) had reached penny stock levels, hitting a...

Wave Life Sciences Ltd.: PRISM Platform and Progress in the {[Potential Treatment]} of Obesity Impress Analysts!

Wave Life Sciences Ltd. (WVE) is a clinical-stage biopharmaceutical company focused on the development...

Neo Performance Materials – A strategic player for critical raw materials with a significant footprint in Europe.

Neo Performance Materials is an exciting company from the field of resource security based in Canada....

Primoris Services is a benefactor of energy infrastructure expansion. A customer's deal and index inclusion provide a boost.

The stock of Primoris Services (PRIM) has shown longer lower wicks repeatedly in recent days, indicating...

Oracle Corp.: Jefferies Sees Approximately 81% Price Potential Following Stock Sell-Off

From Database Giant to Cloud Powerhouse The Oracle Corporation (ORCL), historically known as the leader...

Usa Rare Earth

Speculative Stocks on the Rise – USA Rare Earth Jumps on Board. Equity Interests in Companies in the Critical Minerals Sector Expected to Become "the Norm."

On Thursday (December 4), speculative stocks surged one after another. Among them was the stock of USA...

Robust Stock with AI and Cloud Tailwinds: Ciena Before Quarterly Results in a Seasonally Strong Phase and with Analyst Support Up to $240 (+20%)

The stock of Ciena (CIEN) remains robust just a few days before its quarterly results on December 11....

Praxis Precision Medicines

Praxis Precision Medicines Inc.: BTIG Sees 113% Upside Potential and Names the Stock a Top Pick for 2026

Praxis Precision Medicines Inc. (PRAX) is a biotechnology company that specializes in developing therapies...

Toast Shows Improvement After Market Underperformance. JPMorgan Analysts Upgrade the Stock and Continue to See Opportunity for Top Growth Rates.

The stock of Toast (TOST) continues to lag behind the market but shows signs of improvement as December...

AxoGen receives dual analyst support after FDA approval with targets up to $40 (+40 %)

The stock of AxoGen (AXGN) was recently discussed when it broke out to a new multi-year high. The company...

Vera Therapeutics

Vera Therapeutics: JPMorgan considers drug in IgA nephropathy potentially strategically attractive - Analyst sees 140% upside potential

Vera Therapeutics (VERA) positions itself as a late-stage biotechnology company focused on the development...

Compass Therapeutics: Canaccord Recommends Buy with Nearly 90% Price Potential!

Compass Therapeutics (CMPX) is a biotech company focused on developing innovative immunotherapies against...

Wells Fargo sees Oracle as a potential leader in the “super-cycle” of AI with 40% upside potential.

There was a Oracle (ORCL) sharp pullback after the up-gap, despite the company not only delivering strong...

Ondas Holdings: Revenue Expected to Increase Tenfold by 2028 – Short Ratio Could Propel the Rally Again After New Drone Contract

Ondas Holdings (ONDS) is gaining momentum after consolidating. The company operates in two segments:...

Boeing secures billion-dollar contracts – Defense business is picking up again. More deliveries and positive free cash flow are expected in 2026.

The shares of Boeing (BA) took a significant hit over the summer following the rally in the second quarter....

Annexon

Annexon Inc.: Clear Street Initiates Coverage with a Buy Recommendation and 312% Price Potential!

Annexon Inc. (ANNX) (i.) has recently caught our attention due to an analyst's comment after Wells Fargo...

Synopsys: After three years of sideways movement, the stock could regain momentum following NVIDIA's investment.

Synopsys: After three years of sideways movement, the stock could regain momentum following NVIDIA's...

Kratos Defense delivered solid Q3 growth. Following the price decline, B. Riley analysts see a good risk-reward ratio and 35% upside potential

Kratos Defense & Security Solutions (KTOS) is an incredibly important player in the defense sector....

Neumora Therapeutics

Neumora Therapeutics Inc.: RBC Capital sees 190% Upside Potential!

Neumora Therapeutics Inc. (NMRA) is a biotech company specializing in neuroscience to provide improved...